Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Non Small Cell Lung Cancer Medullary Thyroid Cancer Colon Cancer Breast Cancer Pancreatic Cancer Papillary Thyroid Cancer Other Solid Tumors With Evidence of Activating RET Alteration Thyroid Neoplasms Thyroid Cancer, Papillary Thyroid Diseases Selpercatinib
- currently not accepting new patients, but might later
- Start Date
- Loxo Oncology, Inc.
- Study Type
- Expanded Access
- Last Updated